Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tensin-1 is a large multidomain scaffolding protein that localizes to focal adhesions, specialized plasma membrane structures where it links the actin cytoskeleton to integrin receptors and supports cell-matrix adhesion[2][3][4][1]. It contains a phosphotyrosine-binding domain that interacts with the cytoplasmic tails of β integrins, and a protein tyrosine phosphatase (PTP) domain that is catalytically inactive in Tensin-1, distinguishing it from enzymatically active PTP family members[2][4]. Tensin-1 participates in organizing actin filaments, modulating signaling pathways, and regulating cellular processes such as migration, polarity, and ECM assembly[1][3][4]. Phase separation properties have recently been described, with Tensin-1 forming membraneless biomolecular condensates during focal adhesion disassembly, highlighting a role in cell cycle-dependent adhesion and signaling dynamics[1]. Dysregulation of Tensin-1 expression or post-translational modification is implicated in lung diseases, tissue remodeling, and cancers, but it is not currently a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tensin-1 (TNS1).